Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a broader vitamin mix outperform standard prenatal supplements?

NCT ID NCT07725549

Disease control Sponsor: Indonesia Timur University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a daily multiple micronutrient supplement improves maternal nutrition and birth outcomes more than the standard iron and folic acid supplement. Pregnant women in Indonesia, at 12 weeks gestation or earlier, take one tablet daily for eight weeks. Researchers measure changes in maternal weight, arm circumference, hemoglobin, and zinc levels, as well as infant birth weight.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multiple micronutrient supplement (MMS) compared with iron and folic acid
What this could lead to
If MMS proves superior, it could point toward a better standard prenatal supplement for improving maternal nutrition and reducing low birth weight in similar settings.
What could go wrong
This is a small, early-stage trial with 66 participants, so results may not apply broadly. Differences between groups may be small or not statistically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Jul 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Pregnant women at 12 weeks of gestation or earlier Aged 18 to 40 years No diagnosed chronic disease Willing to complete all study procedures Provided written informed consent Exclusion Criteria: Severe pregnancy complications Known allergy to any supplement ingredient Inability to communicate adequately with the research team Planned relocation from the study area within the following six months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low birth weight are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Birth Weight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low birth weight Maternal anemia Maternal micronutrient status Pregnancy

Contacts and locations

Locations

  • Puskesmas Grobogan

    Purwodadi Grobogan, Central Java, 90222, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.